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A Challenge of Translational Medicine to Space 
Flight
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Consider using a Mathematical or Computational Models-
When the system is complex or complicated enough that your intuition, i.e. your 
forecasting knowledge, is insufficient to describe how the system will respond  
Ultrasound Diagnostics
Insufficient Heart Valves (Perry et al. 1996)
Surgical Intervention
CABG (Bonert et al. 2000)
Bone Fracture 
Risk (Nelson 
et al. 2009)
Space Flight 
Induced Visual 
Impairment  
(Feola et al. 2016)
Renal Stone Incidence Likelihood during Space Flight
• Clinically - Governed by precipitant 
supersaturation and presence of 
inhibitors in urine
• Evidence of altered urine volume and 
chemistry in space
– Lower urine output and elevated calcium 
(bone demineralization)
– Countermeasures that affect urine chemistry
• Citrate treatments, Bisphosphonates, Fluid 
intake, intense exercise (ARED) 
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Bayesian analysis including
– Summary of Urological Diseases in America 2004
– JSC Control Population Data
– In-flight Data (up to ~2010)
Posterior Estimate 
Astronaut – in-flight  365 (+/- 46) events 
per 100K person years 
Does not address gravity, mission 
trades, or countermeasures
– what happens if I reduce water intake by 1 liter?
Bayesian estimate of CaOx stone incidence rate
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Gilkey et al. 2012 – NASA/TP -2012-217120
Prior
Observed Data
Rate of Stone Formation in Context
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Source
NSF Lieske et al. 2006 
(Rochester Study)
SF Urological Diseases In 
America, 2012
Inflight Gilkey et al, 2010
Aviators Porter and Rice , 2013 
Postflight LSAH (Bayesian)
Distributions normalized to equal area under each curve
Probabilistic Model for Renal Stone Incidence 
Likelihood
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Probabilistic Monte Carlo Simulation using Population Data
Problem:  How does space flight and return affect 
the post flight one year rate of stone formation in 
astronauts?
8Biochemistry Model
• Joint Expert Speciation System : JESS
– Development: Peter May  Murdoch University, Western Australia
– compiles 100+ applicable urine chemistry reactions and computes outputs based on 
system parameters and thermodynamics
• Transforms total concentration, via system of equations into free ion 
concentrations (ci) based on urine chemistry reactions
• Relative Supersaturation calcium oxalate (RSCaOx)
– JESS Provides the Saturation Index (SI = RSS2) : Metric that represents the ability of 
spontaneous crystallization of the solution
http://jess.murdoch.edu.au/jess_home.htm
Jess: Effect of Direct Inhibition by Speciation on the 
Urinary CaOx Supersaturation 
(3)
 Microgravity Astronaut: Average of 24-urine excretion rates obtained from 86 
post-flight astronaut urine chemistries. (Whitson et al.36 )
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Renal Stone Population Balance (PBE) System 
Model: Nucleation, Growth & Agglomeration
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Population Balance Equation:  
Nucleation BC:  
Growth Agglomeration-Birth Agglomeration-Death 
Inhibition: Citrate, 
Pyrophosphare, Hydration 
G
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Growth in Nephron CV
Relative Supersaturation
Kidney: 
Mixed 
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Removal 
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Stone Size
(2)
Kassemi M, Thompson DA. Am J Physiol Renal Physiol. 2016 - Microgravity
Kassemi M, Thompson DA. Am J Physiol Renal Physiol. 2016  - Dietary
PBE Model : Dietary Countermeasures for 
Microgravity Astronaut Subject: Effect of Citrate   
(4)
nominal urine 
concentrations 
(hypocitraturia) 
Citrate Concentration
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Representative Output  - PBE Model Max Stone Size
Kassemi PBE model 
produces a population 
density of stones related 
to the input urine 
chemistry
Max Stone Size as the 
maximum stone 
Diameter predicted to 
have >1 stone/mL of 
urine
Correlate Stone Size to Rate of Occurrence: 
Poisson Regression based Transfer Function
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PBE Max Stone size from known urine chemistries
Incidence rates distributions from population based observations
Randomly assess the number of 
incidences for fixed time interval 
assuming the corresponding 
incidence rate distribution
Matches each set of 
incidences to a 
corresponding Poison 
distribution
Aggregates the distributions and calculates the 
standard deviation
Repeats 
10,000 
times
Technique: 
Poisson 
Regression 
With Rates 
Rate of Stone Formation in Context
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Type A B C Source
NSF Normal Mean :101.1 Std:101.3 Lieske et al. 2006 
(Rochester Study)
SF Triangular Min:
121
Max: 1093 ML: 976 Urological Diseases 
In America, 2012
Inflight Lognormal Mean:365 Std:46 Gilkey et al, 2010
Postflight Gamma alpha=
7.77
beta=.00593 Porter and Rice ,
2013 & LSAH
Dataset Sources: Training and Testing
• LSAH Population Data
1517 Urine Samples from 581 individual astronauts (pre-, in-, and post-) flight 
– Data to TRAIN the model
• 957 urine samples, from the Preflight, and Post flight datasets
– Inflight was omitted to be used to test the model 
• Preflight
– 515 astronaut urine samples, including 13 stoneformer samples
• Postflight
– 442 astronaut urine samples, including 13 stoneformer samples
– To TEST the model
• 560 Urine samples
• Incomplete Preflight and Postflight data 
– eg. pH was not measured in all cases so a distribution created from the data that did include preflight was 
used to determine the pH for the dataset
• Inflight data both complete and incomplete was used to form the Inflight renal chemistry 
distributions
• Whitson et al. J Urology 2009 
• Urine samples 9 astronauts, at each flight phase that received potassium citrate as part of a 
study on renal risk formation in spaceflight.
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Simulation analysis - Correlation of Rates
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Simulation of Astronaut Population Risk  -
Convergence of Simulation
Mean
Standard Deviation of 
the Mean
PreFlight 5.4697E-03 4.9452E-03
PostFlight 6.4767E-03 1.4341E-02
Inflight 6.8544E-03 1.3473E-02
Convergence Values : Incidence per Person Years
Astronaut Population Incidence Rates: 
Preflight, Inflight, and Postflight
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1.5 IQR
1st – 3rd Qr
Median
Mean
Sampled Incidence Rate Per Person-Year
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Incidence Rate Histograms: Preflight
Sampled Incidence Rate Per Person Year
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Incidence Rate Histograms: Inflight
Sampled Incidence Rate Per Person Year
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Incidence Rate Histograms: Postflight
Inhibition Factors: Dietary Citrate and Placebo
Whitson et al. J Urology 2009 
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Note: Data included only 2 placebo subjects, totaling 14 urine samples
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Summary of Findings
• We have shown that combining physics based modeling and 
numerical analytics provides deeper insight into the renal 
stone risks for astronauts
– PBE forecasts an increase in the extent of possible incidence rates due to 
space flight and return then supersaturation alone
• Adding PBE/kinetics appears to be provide a higher predictive resolution at SI > 5
– Revelation of a possible second mode
• Minimal attributable difference in predictive potential at lower SI levels typical of 
non-stone former, pre-flight rates
– Consistent with published findings of underlying PBE model in assess the 
effects of inhibition
• Citrate has minor impact above normal levels
• We cannot assess if this particular application illustrates 
overall better forecasting for the general population
– Does indicate a better means to quantify the relative change in risk to 
astronauts
– Provides the opportunity to glean some insight into the efficacy of 
interventions that modify
• Effect of hydration
• Effect of inhibitors   
• Effect of reducing urinary calcium through other countermeasures (exercise) 
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Assumptions and Limitations
• Possibility the data does not correlate to the 
rates specified
– Renal Stone occurrence rate is multifactorial
• Unique anatomy plays a role
• Gravity vector and wall interactions affect residence time
– Timing
• Astronaut urine chemistries does not address relative 
timing of the sample acquisition and any stone occurrence 
– Data not separated for sex, gender or any age factors
• PBE model has wide range of values for 
kinetics factors Kg, Kb, b
– Values are not known with precision and may 
potentially represent a source of large uncertainty in 
the analysis
• May not accurately assess the range of effects of inhibition
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Conclusions and future work
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Future Work
• Complete the current analysis
• Peer Review of the work
– Formal panel review and/or Peer publication(s)
• Validation And Credibility
– Used a referent data for performance assessment and 
validation
• Partnered with researchers at Cleveland Clinic to identify 
appropriate data
Credible Practices For Models and Simulations
• Models and simulations of all types governed by NASA-STD-7009a
– Communications tool that seeks to specify the credibility (degree of 
trustworthiness) of the model or specific simulation to the context of it’s 
application
Data Pedigree - Verification – Validation – Input Pedigree – Uncertainty 
Characterization – Robustness (Sensitivity) – Use History – Product Management   
• The NIH Committee on Credible Practice of Modeling & Simulation 
in Healthcare
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Web: https://simtk.org/home/cpms
e-mail: cpmsinhealthcare@gmail.com
National Aeronautics and Space AdministrationNational Aeronautics and Sp ce Administration
Thank you!
Questions?
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Whitson
Rate of Stone Formation in Context
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Source
NSF Lieske et al. 2006 
(Rochester Study)
SF Urological
Diseases In 
America, 2012
Inflight Gilkey et al, 2010
Aviators Porter and Rice ,
2013 
Postflight LSAH (Bayesian)
Distributions normalized to equal area under each curve
Break the problem down into constitutive 
information
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Observed 
Rates of Stone 
Presentation
Crystal Growth 
and Agglomeration
Chemical Relations 
Between Species: 
Supersaturation
24-hour 
Output Urine 
Chemistry
Problem:  How does space flight and return affect 
the post flight one year rate of stone formation in 
astronauts?
Data Driven 
Transformation 
Function : 
Estimating Rate 
of Treatable 
Occurrence
Max Stone Size vs SI – Input Data
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Sampled Incidence Rate Per Person Year
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Result 1
Sampled Incidence Rate Per Person Year
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Result 1
Sampled Incidence Rate Per Person Year
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Result 1
Whitson Combined
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Max Stone Size Per Flight Phase
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set(findobj(gca,'type','line'),'linew',2)
Add Preflight, Postflight, and Inflight Boxplots
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SI Per Flight Phase
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set(findobj(gca,'type','line'),'linew',2)
SI Incidence Per Flight Phase
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set(findobj(gca,'type','line'),'linew',2)
